Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

RPI Finance Trust — Epizyme, Inc. insider: 3 transactions · InsiderLens

Home / Insiders / RPI Finance Trust

RPI Finance Trust

Director at Epizyme, Inc. · on record since Nov 8, 2019
10% owner at Epizyme, Inc. · on record since Feb 13, 2020

Insider trading activity of RPI Finance Trust

Transactions on record: 3; since Jun 15, 2021

Open-market buys: 1; $34M

Open-market sells: 0

Companies traded: 1; last filing Feb 1, 2022

Figures computed from official regulatory filings — methodology.

Companies where RPI Finance Trust has traded

Epizyme, Inc.3 tx · $34.3M · Feb 1, 2022

Track record of RPI Finance Trust

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of RPI Finance Trust

Co-insiders of RPI Finance Trust

Agarwal ShefaliEpizyme, Inc.
Allen Andrew REpizyme, Inc.
AMGEN INCEpizyme, Inc.
Amgen Ventures LLCEpizyme, Inc.
Astellas Venture Fund I L.P.Epizyme, Inc.
Astellas Venture Management LLCEpizyme, Inc.
BARRETT M JAMESEpizyme, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

BARRIS PETER JEpizyme, Inc.

BASKETT FORESTEpizyme, Inc.

BATE KENNETHEpizyme, Inc.

Bay City Capital Fund V Co-Investment Fund LPEpizyme, Inc.

Bay City Capital Fund V, L.P.Epizyme, Inc.

BAY CITY CAPITAL LLCEpizyme, Inc.

Bay City Capital Management V LLCEpizyme, Inc.

Bazemore Robert BEpizyme, Inc.

Beaulieu JosephEpizyme, Inc.

BEVERIDGE, ROY AEpizyme, Inc.

Bogle Grant C.Epizyme, Inc.

CELGENE CORP /DE/Epizyme, Inc.

Celgene European Investment Co LLCEpizyme, Inc.

Conroy Kevin TEpizyme, Inc.

Copeland Robert AEpizyme, Inc.

Daniel Thomas OEpizyme, Inc.

DRANT RYAN DEpizyme, Inc.

EVNIN LUKEEpizyme, Inc.

Fleming SuzanneEpizyme, Inc.

Foley ToddEpizyme, Inc.

GADICKE ANSBERTEpizyme, Inc.

Garbacz StephenEpizyme, Inc.

Giordano Michael FEpizyme, Inc.

GOLDFISCHER CARLEpizyme, Inc.

Gould Robert JEpizyme, Inc.

Graf Susan EEpizyme, Inc.

Hedrick EricEpizyme, Inc.

Ho Peter Tai-ChingEpizyme, Inc.

Horvitz H RobertEpizyme, Inc.

KAILIAN VAUGHN MEpizyme, Inc.

KERINS PATRICK JEpizyme, Inc.

KLEINER PERKINS CAUFIELD & BYERS XIII, LLCEpizyme, Inc.

KOLLURI KRISHNA KITTUEpizyme, Inc.

Korn JeraldEpizyme, Inc.

KPCB XIII Associates, LLCEpizyme, Inc.

Kutok JefferyEpizyme, Inc.

Legorreta Pablo G.Epizyme, Inc.

MOTT DAVID MEpizyme, Inc.

MPM Asset Management Investors BV4 LLCEpizyme, Inc.

MPM BioVentures IV GmbH & Co. Beteiligungs KGEpizyme, Inc.

MPM BioVentures IV GP LLCEpizyme, Inc.

MPM BioVentures IV LLCEpizyme, Inc.

MPM BioVentures IV QP LPEpizyme, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Epizyme, Inc.	Feb 1, 2022	Buy	22,666,667	1.50 USD	$34M	SEC
Epizyme, Inc.	Jun 15, 2021	AwardD	40,559	8.53 USD	$346K	SEC
Epizyme, Inc.	Jun 15, 2021	AwardD	8,060	0.00 USD	$0	SEC